It promotes triglyceride level and adipose deposition within HepG2 cells, and induces diabetes‐associated metabolic diseases like insulin resistance and hyperglycemia by decreasing miR‐192‐5p and increasing its downstream TF FOXO1.233. The gene discussed is FOXO1; the disease is Hyperglycemia.